85 related articles for article (PubMed ID: 3264362)
1. Origin of the soluble interleukin-2 receptor in the serum of patients with hairy cell leukemia.
Semenzato G; Trentin L; Zambello R; Agostini C; Bulian P; Siviero F; Ambrosetti A; Vinante F; Prior M; Chilosi M
Leukemia; 1988 Dec; 2(12):788-92. PubMed ID: 3264362
[TBL] [Abstract][Full Text] [Related]
2. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
Srivastava MD; Srivastava A; Srivastava BI
Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment.
Lauria F; Rondelli D; Raspadori D; Zinzani PL; Benfenati D; Pileri S; Sabattini E; Tura S
Leuk Lymphoma; 1992 May; 7(1-2):103-7. PubMed ID: 1472920
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders.
Trentin L; Cerutti A; Zambello R; Sancretta R; Tassinari C; Facco M; Adami F; Rodeghiero F; Agostini C; Semenzato G
Blood; 1996 Apr; 87(8):3327-35. PubMed ID: 8605349
[TBL] [Abstract][Full Text] [Related]
5. Serum soluble IL-2 receptor as a reliable and noninvasive marker of disease activity in patients with hairy cell leukemia.
Chrobák L; Podzimek K; Plísková L; Kerekes Z; Zák P; Voglová J; Spacek J; Palicka V
Neoplasma; 1996; 43(5):321-5. PubMed ID: 8996552
[TBL] [Abstract][Full Text] [Related]
6. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity.
Chilosi M; Semenzato G; Cetto G; Ambrosetti A; Fiore-Donati L; Perona G; Berton G; Lestani M; Scarpa A; Agostini C
Blood; 1987 Nov; 70(5):1530-5. PubMed ID: 3117133
[TBL] [Abstract][Full Text] [Related]
7. Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors.
Trentin L; Pizzolo G; Zambello R; Agostini C; Morosato L; Sancetta R; Adami F; Vinante F; Chilosi M; Gallati H
Leukemia; 1995 Jun; 9(6):1051-5. PubMed ID: 7596168
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
Trentin L; Zambello R; Benati C; Cassatella M; Agostini C; Bulian P; Adami F; Carra G; Pizzolo G; Semenzato G
Cancer Res; 1992 Oct; 52(19):5223-8. PubMed ID: 1394125
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemia.
Cimino G; Annino L; Giona F; Sgadari C; Di Gregorio AO; Cava MC; Cimino G; Mandelli F
Leukemia; 1991 Jul; 5(7):602-5. PubMed ID: 2072745
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural, immunologic and clinical follow-up of five patients with HCL treated with interferon (IFN) for more than three years.
Mantovani G; Astara G; Curreli L; Lai P; Turnu E; Locci F; Lantini MS; Cossu M; Riva A; Del Giacco GS
Haematologica; 1992; 77(4):326-35. PubMed ID: 1427443
[TBL] [Abstract][Full Text] [Related]
11. Serum interleukin 1 beta levels as a marker in hairy cell leukemia: correlation with disease status and sIL-2R levels.
Barak V; Nisman B; Dann EJ; Kalickman I; Ruchlemer R; Bennett MA; Polliack A
Leuk Lymphoma; 1994; 14 Suppl 1():33-9. PubMed ID: 7820051
[TBL] [Abstract][Full Text] [Related]
12. Constitutive production of tumor necrosis factor-alpha in hairy cell leukemia: possible role in the pathogenesis of the cytopenia(s) and effect of treatment with interferon-alpha.
Foa R; Guarini A; Francia di Celle P; Trentin L; Gillio Tos A; Bellone G; Carbone A; Attisano C; Massaia M; Raspadori D
J Clin Oncol; 1992 Jun; 10(6):954-9. PubMed ID: 1588375
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk.
Ambrosetti A; Semenzato G; Prior M; Chilosi M; Vinante F; Vincenzi C; Zanotti R; Trentin L; Portuese A; Menestrina F
Br J Haematol; 1989 Oct; 73(2):181-6. PubMed ID: 2818938
[TBL] [Abstract][Full Text] [Related]
14. Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.
Arun B; Curti BD; Longo DL; Stevens D; Alvord WG; Gause BL; Watson T; Kopp WC; Janik JE
Cancer J Sci Am; 2000; 6(1):21-4. PubMed ID: 10696734
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia.
Richards JM; Mick R; Latta JM; Daly K; Ratain MJ; Vardiman JW; Golomb HM
Blood; 1990 Nov; 76(10):1941-5. PubMed ID: 1700727
[TBL] [Abstract][Full Text] [Related]
16. Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia.
Chilosi M; Pizzolo G; Semenzato G; Cetto GL
Int J Biol Markers; 1986; 1(2):101-4. PubMed ID: 3123562
[TBL] [Abstract][Full Text] [Related]
17. Biological markers and minimal residual disease in hairy cell leukemia.
Lauria F; Raspadori D; Benfenati D; Rondelli D; Pallotti A; Tura S
Leukemia; 1992 Nov; 6 Suppl 4():149-51. PubMed ID: 1359204
[TBL] [Abstract][Full Text] [Related]
18. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
20. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
